Scalado is a world leader in the mobile imaging industry, with a long history of developing innovative platform-independent imaging solutions. Based on Scalado’s unique Random Access JPEG and more than 50 patent and patent pending technologies, these innovations are currently being used by the world’s leading global telecom and platform players in over 1 billion mobile devices, a figure that is growing with over 500 million devices each year.
Since the start, the company’s mission has been to help camera and mobile phone manufacturers to significantly improve their imaging solutions in order to deliver an optimal end-user experience. Scalado helps companies shorten their time-to-market and differentiate their products through imaging solutions that offer top of the line advantages in editing, enhancing, viewing and sending images.
Scalado’s technology has gained worldwide recognition by all of the major players in the IT industry. The company already licenses its solutions to the top five tier 1 mobile phone manufacturers, top 10 ISP/Sensor companies, and most leading platform providers. As a result, when someone is using a camera phone, it’s very likely that Scalado’s patented imaging platform is onboard.
Through the years, the company has received several awards for innovation and excellence in export. In 2010, Scalado was bestowed the Hermes Export Award by the Swedish Chamber of Commerce on World Trade Day, and listed as one of the fastest growing companies in EMEA.
Scalado has offices in Sweden (HQ), Korea, China, Taiwan, Singapore and the United States. The company employs around 110 people, most of them working at its Swedish HQ in Lund. Scalado has been doubling its revenues year on year since 2007.
Scalado™ has triple-A, the highest credit rating in the Soliditet evaluation system, which is based on approximately 2,400 decision parameters.
Scalado is a corporate supporter of Médecins Sans Frontières (MSF). MSF is an international, independent, medical humanitarian organisation that delivers emergency aid to people affected by armed conflict, epidemics, natural disasters and exclusion from healthcare.